Quasi-randomized trial shows CO2 laser improves symptoms in women with GSM, suggesting an effective alternative treatment.
Objective: To compare the effectiveness of pixel CO2 laser and vaginal promestriene in treating genitourinary syndrome of menopause (GSM). Methods: A quasi-randomized controlled trial was conducted with 48 patients. CO2 Laser Group (24 patients) received 3 sessions of vaginal pixel CO2 laser, and promestriene group (24 patients) used vaginal promestriene daily for 14 days, […]
No takes yet. Share an insight, caveat, or question.
Beckhauser et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: